Tesamorelin: GHRH Analog and Growth Hormone Research
Share
Among GHRH analogs studied in metabolic research, Tesamorelin stands out for the depth of its characterization, particularly in visceral adipose tissue models.
Overview
Tesamorelin is a synthetic peptide designed as an analog of GHRH (growth hormone-releasing hormone). It is studied for its ability to stimulate endogenous pulsatile growth hormone release via the GHRH receptor.
Proposed mechanism of action
By binding to the GHRH receptor at the pituitary level, Tesamorelin is studied for its effect on GH secretion pulsatility and, downstream, on IGF-1 signaling. A significant portion of the research literature also focuses on its interaction with visceral adipose tissue models.
Scientific research focus
- Research on visceral adipose tissue
- Studies on the growth hormone axis
- IGF-1 signaling
- Metabolic research models
Purity & quality standards
CELLOVATE applies strict internal standards to ensure consistency and reliability:
- High-purity peptide structure (≥99% HPLC)
- Independent third-party verification, batch by batch
- Batch-to-batch consistency
- Lyophilized form, nitrogen-sealed for stability
Storage & handling
Tesamorelin is supplied as a lyophilized powder. Once reconstituted, it should be stored between 2 and 8°C and used within the timeframe indicated on the supplied certificate of analysis.
Research use only
Tesamorelin is offered strictly as a research reagent for in-vitro and laboratory studies conducted by qualified professionals. It is not a drug, supplement, or cosmetic, and is not intended for human or animal use.
